• français
    • English
    français
  • Login
Help
View Item 
  •   Home
  • Laboratoire Conception de Produits et Innovation (LCPI)
  • View Item
  • Home
  • Laboratoire Conception de Produits et Innovation (LCPI)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Eco-design and medicine: Opportunities to implement eco-design in the pharmaceutical R&D process

Article dans une revue avec comité de lecture
Author
LUU, Duc-Nam
127758 Laboratoire Conception de Produits et Innovation [LCPI]
GACHET, Hervé
1136266 Sanofi Gentilly [Sanofi Gentilly]
MAIER, Claus-Jürgen
1002607 Sanofi-Aventis Deutschland GmbH [Francfort, Allemagne]
MARANZANA, Nicolas
127758 Laboratoire Conception de Produits et Innovation [LCPI]
AOUSSAT, Améziane
127758 Laboratoire Conception de Produits et Innovation [LCPI]

URI
http://hdl.handle.net/10985/22737
DOI
10.1016/j.jclepro.2022.132785
Date
2022-06-19
Journal
Journal of Cleaner Production

Abstract

The pharmaceutical sector has the societal duty to make medical healthcare products both available and affordable. But like any human activity, it is not neutral in terms of environmental impact. Therefore, and like any industry, the pharmaceutical sector needs to consider the environmental aspects into its product design and activities in order to reach a sustainable production and consumption patterns, as defined by the Sustainable Development Goal (SDG) 12 of the United Nations. With a holistic perspective, the eco-design concept is an approach that aims to integrate environmental aspects into product design. To contribute to the SDGs, the pharmaceutical industry needs to consider the environmental impacts of its products. Usually, experts within Research & Development (R&D) do not have the proper level of knowledge to integrate the environmental aspects, in a Lifecycle perspective, into their decision making. Even so, those parameters are not yet part of the New Product Development (NPD) process of the medicine product. With those elements in mind, the aim of this paper is to understand which phases of the pharmaceutical R&D process represent an opportunity to eco-design such products. We proposed two qualitative experimentations with, first interviewing ten practitioners of R&D; and second, with an assessment of the medicine NPD process and related deliverables, based on LCA results. The use of such results to investigate potential key contributors during NPD stages does not seem to be explored yet, especially for the pharmaceutical sector. Results show that eco-design approaches can be performed all along the development of a pharmaceutical product. Main eco-design levers appear in parallel to the clinical phases 2a and 2b, in other words, when the tests on the final marketed form are initiated.

Files in this item

Name:
LCPI_JCP_2022_LUU.pdf
Size:
2.286Mb
Format:
PDF
Embargoed until:
2022-12-20
View/Open

Collections

  • Laboratoire Conception de Produits et Innovation (LCPI)

Related items

Showing items related by title, author, creator and subject.

  • Integration of environmental assessment in a PLM context: a case study in luxury industry 
    Article dans une revue avec comité de lecture
    YOUSNADJ, Djamel; JOUANNE, Guillaume; MARANZANA, Nicolas; SEGONDS, Frédéric; BOUCHARD, Carole; AOUSSAT, Améziane (Springer, 2014)
    Nowadays, the environment becomes a major issue in our society. It gives rise to regu-lations, market demand and stakeholder's pressure which are concerning companies. These latter have to reduce the negative impact of ...
  • Biomimetics: process, tools and practice 
    Article dans une revue avec comité de lecture
    FAYEMI, Pierre-Emmanuel; WANIECK, Kristina; ZOLLFRANK, C; MARANZANA, Nicolas; AOUSSAT, Améziane (IOP Publishing, 2017)
    Biomimetics applies principles and strategies abstracted from biological systems to engineering and technological design. With a huge potential for innovation, biomimetics could evolve into a key process in businesses. Yet ...
  • The value of TRIZ and its derivatives for interdisciplinary group problem solving 
    Article dans une revue avec comité de lecture
    SCHÖFER, Malte; MARANZANA, Nicolas; AOUSSAT, Améziane; GAZO, Claude; BERSANO, Giacomo (Elsevier, 2015)
    The value of TRIZ for technological problem solving is widely recognized. Initially designed for an inventor working (alone) on a technical problem, it is today often used as a tool for group creativity. In this article, ...
  • Linkage, an Online Tool to Support Interdisciplinary Biomimetic Design Teams 
    Article dans une revue avec comité de lecture
    GRAEFF, Eliot; MARANZANA, Nicolas; AOUSSAT, Améziane (ASME, 2021-10)
    Implementation of biomimetics in practical innovation strategies still faces various impediments. Multidisciplinary communication is one of the most recognized one. Enabling teammates having various cognitive and conceptual ...
  • Biomimetics, where are the biologists? 
    Article dans une revue avec comité de lecture
    GRAEFF, Eliot; MARANZANA, Nicolas; AOUSSAT, Améziane (Taylor & Francis, 2019)
    Engineering design, as the science framing the practice of design through the elaboration of tools and processes, is constantly evolving towards new innovative strategies. To thrive in their extremely competitive environment, ...

Browse

All SAMCommunities & CollectionsAuthorsIssue DateCenter / InstitutionThis CollectionAuthorsIssue DateCenter / Institution

Newsletter

Latest newsletterPrevious newsletters

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

ÉCOLE NATIONALE SUPERIEURE D'ARTS ET METIERS

  • Contact
  • Mentions légales

ÉCOLE NATIONALE SUPERIEURE D'ARTS ET METIERS

  • Contact
  • Mentions légales